Achievement of field-reversed configuration plasma sustainment via 10 MW neutral-beam injection on the C-2U device, Gota, H., Binderbauer, M.W., Tajima, T., Putvinski, S., Tuszewski, M., Dettrick, S., Garate, E., Korepanov, S., Smirnov, A., Thompson, M.C., Trask, E., Yang, X., Schmitz, L., Lin, Z., Ivanov, A.A., Asai, T., Allfrey, I., Andow, R., Beall, M., Bolte, N., Bui, D.Q., Cappello, M., Ceccherini, F., Clary, R., Cheung, A.H., Conroy, K., Deng, B.H., Douglass, J., Dunaevsky, A., Feng, P., Fulton, D., Galeotti, L., Granstedt, E., Griswold, M., Gupta, D., Gupta, S., Hubbard, K., Isakov, I., Kinley, J.S., Knapp, K., Magee, R., Matvienko, V., Mendoza, R., Mok, Y., Necas, A., Primavera, S., Onofri, M., Osin, D., Rath, N., Roche, T., Romero, J., Schindler, T., Schroeder, J.H., Sevier, L., Sheftman, D., Sibley, A., Song, Y., Steinhauer, L.C., Valentine, T., Van Drie, A.D., Walters, J.K., Waggoner, W., Yushmanov, P., Zhai, K., The TAE Team
No takes yet. Share an insight, caveat, or question.
Gota et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: